Flamingo is pioneering RNA-targeted therapies for oncology with a clinical-stage pipeline targeting undruggable transcription factors and long non-coding RNAs. Flamingo has an alliance with Ionis ...
LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA, Oct. 17, 2023 /PRNewswire/ -- Flamingo Therapeutics ("Flamingo") today announced the presentation of a "Trials-in-Progress", or TiP, poster at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results